Omeprazole antagonizes virulence and inflammation in Salmonella enterica-infected RAW264.7 cells

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 6, 2009, Pages 2402-2409

  Puiac, Speranta ^a   Negrea, Aurel ^a   Richter Dahlfors, Agneta ^a   Plant, Laura ^a   Rhen, Mikael ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BAFILOMYCIN A1; I KAPPA B; I KAPPA B ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; NITRIC OXIDE; OMEPRAZOLE; TETRACYCLINE; TUMOR NECROSIS FACTOR ALPHA; VIRULENCE FACTOR;

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG CYTOTOXICITY; DRUG MECHANISM; HOST CELL; IN VITRO STUDY; INFLAMMATION; MOUSE; NONHUMAN; PATHOGENICITY ISLAND; PRIORITY JOURNAL; PROTEIN DEGRADATION; SALMONELLA ENTERICA; SALMONELLA PATHOGENICITY ISLAND 2; SALMONELLA TYPHIMURIUM; SEROTYPE; TYPE III SECRETION SYSTEM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CELL SURVIVAL; GENOMIC ISLANDS; MACROLIDES; MACROPHAGES; MICE; MICE, INBRED BALB C; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OMEPRAZOLE; PROTON PUMP INHIBITORS; SALMONELLA ENTERICA; VACUOLES; VIRULENCE;

EID: 67049145610     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01483-08     Document Type: Article

References (45)

1. Beuzón, C. R., G. Banks, J. Deiwick, M. Hensel, and D. W. Holden. 1999. pH-dependent secretion of SseB, a product of the SPI-2 type III secretion system of Salmonella typhimurium. Mol. Microbiol. 33:806-816.
2. Beuzón, C. R., S. Meresse, K. E. Unsworth, J. Ruiz-Albert, S. Garvis, S. R. Waterman, T. A. Ryder, E. Boucrot, and D. W. Holden. 2000. Salmonella maintains the integrity of its intracellular vacuole through the action of SifA. EMBO J. 19:3235-3249.
3. Bjur, E., S. Eriksson-Ygberg, F. Aslund, and M. Rhen. 2006. Thioredoxin 1 promotes intracellular replication and virulence of Salmonella enterica serovar Typhimurium. Infect. Immun. 74:5140-5151.
4. Bjur, E., S. Eriksson-Ygberg, and M. Rhen. 2006. The O-antigen affects replication of Salmonella enterica serovar Typhimurium in murine macrophage-like J774-A.1 cells through modulation of host cell nitric oxide production. Microbes Infect. 8:1826-1838.
5. Capodicasa, E., P. Cornacchione, B. Natalini, A. Bartoli, S. Coaccioli, P. Marconi, and L. Scaringi. 2008. Omeprazole induces apoptosis in normal human polymorphonuclear leucocytes. Int. J. Immunopathol. Pharmacol. 21:73-85.
6. Chakravortty, D., I. Hansen-Wester, and M. Hensel. 2002. Salmonella pathogenicity island 2 mediates protection of intracellular Salmonella from reactive nitrogen intermediates. J. Exp. Med. 195:1155-1166.
7. Chakravortty, D., M. Rohde, L. Jager, J. Deiwick, and M. Hensel. 2005. Formation of a novel surface structure encoded by Salmonella pathogenicity island 2. EMBO J. 24:2043-2052.
8. De Milito, A., E. Iessi, M. Logozzi, F. Lozupone, M. Spada, M. L. Marino, C. Federici, M. Perdicchio, P. Matarrese, L. Lugini, A. Nilsson, and S. Fais. 2007. Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species. Cancer Res. 67:5408-5417. (Pubitemid 46997281)
9. Dramsi, S., and P. Cossart. 2002. Listeriolysin O: a genuine cytolysin optimized for an intracellular parasite. J. Cell Biol. 156:943-946. (Pubitemid 34839843)
10. Eriksson, S., J. Bjorkman, S. Borg, A. Syk, S. Pettersson, D. I. Andersson, and M. Rhen. 2000. Salmonella typhimurium mutants that downregulate phagocyte nitric oxide production. Cell Microbiol. 2:239-250.
11. Eriksson, S., S. Lucchini, A. Thompson, M. Rhen, and J. C. Hinton. 2003. Unravelling the biology of macrophage infection by gene expression profiling of intracellular Salmonella enterica. Mol. Microbiol. 47:103-118. (Pubitemid 36051327)
12. Freeman, J. A., M. E. Ohl, and S. I. Miller. 2003. The Salmonella enterica serovar Typhimurium translocated effectors SseJ and SifB are targeted to the Salmonella-containing vacuole. Infect. Immun. 71:418-427.
13. Galán, J. E. 2001. Salmonella interactions with host cells: type III secretion at work. Annu. Rev. Cell Dev. Biol. 17:53-86.
14. Gauthier, A., M. L. Robertson, M. Lowden, J. A. Ibarra, J. L. Puente, and B. B. Finlay. 2005. Transcriptional inhibitor of virulence factors in enteropathogenic Escherichia coli. Antimicrob. Agents Chemother. 49:4101-4109.
15. Hansen-Wester, I., and M. Hensel. 2001. Salmonella pathogenicity islands encoding type III secretion systems. Microbes Infect. 3:549-559.
16. Hautefort, I., M. J. Proenca, and J. C. Hinton. 2003. Single-copy green fluorescent protein gene fusions allow accurate measurement of Salmonella gene expression in vitro and during infection of mammalian cells. Appl. Environ. Microbiol. 69:7480-7491.
17. Hinoki, A., K. Yoshimura, K. Fujita, M. Akita, R. Ikeda, M. Nagashima, M. Nomura, and A. Satomi. 2006. Suppression of proinflammatory cytokine production in macrophages by lansoprazole. Pediatr. Surg. Int. 22:915-923.
18. Hong, J., Y. Nakano, A. Yokomakura, K. Ishihara, S. Kim, Y. S. Kang, and K. Ohuchi. 2006. Nitric oxide production by the vacuolar-type (H+)-ATPase inhibitors bafilomycin A1 and concanamycin A and its possible role in apoptosis in RAW 264.7 cells. J. Pharmacol. Exp. Ther. 319:672-681.
19. Hung, D. T., and E. J. Rubin. 2006. Chemical biology and bacteria: not simply a matter of life or death. Curr. Opin. Chem. Biol. 10:321-326.
20. Hung, D. T., E. A. Shakhnovich, E. Pierson, and J. J. Mekalanos. 2005. Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization. Science 310:670-674.
21. Kauppi, A. M., R. Nordfelth, H. Uvell, H. Wolf-Watz, and M. Elofsson. 2003. Targeting bacterial virulence: inhibitors of type III secretion in Yersinia. Chem. Biol. 10:241-249. (Pubitemid 36380281)
22. Keyser, P., M. Elofsson, S. Rosell, and H. Wolf-Watz. 2008. Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against gram-negative bacteria. J. Intern. Med. 264:17-29.
23. Kuhle, V., and M. Hensel. 2004. Cellular microbiology of intracellular Salmonella enterica: functions of the type III secretion system encoded by Salmonella pathogenicity island 2. Cell Mol. Life. Sci. 61:2812-2826.
24. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
25. Löber, S., D. Jackel, N. Kaiser, and M. Hensel. 2006. Regulation of Salmonella pathogenicity island 2 genes by independent environmental signals. Int. J. Med. Microbiol. 296:435-447.
26. +-ATPase in vesicular trafficking: targeting, regulation and function. Curr. Opin. Cell Biol. 20:415-426.
27. Merlen, C., D. Fayol-Messaoudi, S. Fabrega, T. El Hage, A. Servin, and F. Authier. 2005. Proteolytic activation of internalized cholera toxin within hepatic endosomes by cathepsin D. FEBS J. 272:4385-4397. (Pubitemid 41284412)
28. Miguel, D. C., J. K. Yokoyama-Yasunaka, W. K. Andreoli, R. A. Mortara, and S. R. Uliana. 2007. Tamoxifen is effective against Leishmania and induces a rapid alkalinization of parasitophorous vacuoles harbouring Leishmania (Leishmania) amazonensis amastigotes. J. Antimicrob. Chemother. 60:526-534.
29. Morimura, T., K. Fujita, M. Akita, M. Nagashima, and A. Satomi. 2008. The proton pump inhibitor inhibits cell growth and induces apoptosis in human hepatoblastoma. Pediatr. Surg. Int. 24:1087-1094.
30. Muschiol, S., L. Bailey, A. Gylfe, C. Sundin, K. Hultenby, S. Bergstrom, M. Elofsson, H. Wolf-Watz, S. Normark, and B. Henriques-Normark. 2006. A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis. Proc. Natl. Acad. Sci. USA 103:14566-14571. (Pubitemid 44484790)
31. Negrea, A., E. Bjur, S. E. Ygberg, M. Elofsson, H. Wolf-Watz, and M. Rhen. 2007. Salicylidene acylhydrazides that affect type III protein secretion in Salmonella enterica serovar Typhimurium. Antimicrob. Agents Chemother. 51:2867-2876.
32. Nordfelth, R., A. M. Kauppi, H. A. Norberg, H. Wolf-Watz, and M. Elofsson. 2005. Small-molecule inhibitors specifically targeting type III secretion. Infect. Immun. 73:3104-3114.
33. +-ATPase inhibitor bafilomycin A1. Mol. Biol. Cell 9:3561-3578.
34. Pósfai, G., M. D. Koob, H. A. Kirkpatrick, and F. R. Blattner. 1997. Versatile insertion plasmids for targeted genome manipulations in bacteria: isolation, deletion, and rescue of the pathogenicity island LEE of the Escherichia coli O157:H7 genome. J. Bacteriol. 179:4426-4428. (Pubitemid 27291081)
35. Rathman, M., M. D. Sjaastad, and S. Falkow. 1996. Acidification of phagosomes containing Salmonella typhimurium in murine macrophages. Infect. Immun. 64:2765-2773.
36. Rhen, M., and C. J. Dorman. 2005. Hierarchical gene regulators adapt Salmonella enterica to its host milieus. Int. J. Med. Microbiol. 294:487-502.
37. Steele-Mortimer, O. 2008. Infection of epithelial cells with Salmonella enterica. Methods Mol. Biol. 431:201-211.
38. Steele-Mortimer, O., M. St.-Louis, M. Olivier, and B. B. Finlay. 2000. Vacuole acidification is not required for survival of Salmonella enterica serovar Typhimurium within cultured macrophages and epithelial cells. Infect. Immun. 68:5401-5404.
39. Sun-Wada, G. H., Y. Wada, and M. Futai. 2004. Diverse and essential roles of mammalian vacuolar-type proton pump ATPase: toward the physiological understanding of inside acidic compartments. Biochim. Biophys. Acta 1658:106-114.
40. +-ATPase and induces lysosomal enzyme secretion in macrophages. J. Cell Physiol. 163:137-144.
41. van Weert, A. W., H. J. Geuze, and W. Stoorvogel. 1997. Heterogeneous behavior of cells with respect to induction of retrograde transport from the trans-Golgi network to the Golgi upon inhibition of the vacuolar proton pump. Eur. J. Cell Biol. 74:417-423.
42. Vazquez-Torres, A., J. Jones-Carson, P. Mastroeni, H. Ischiropoulos, and F. C. Fang. 2000. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro. J. Exp. Med. 192:227-236.
43. Williamson, L. C., and E. A. Neale. 1994. Bafilomycin A1 inhibits the action of tetanus toxin in spinal cord neurons in cell culture. J. Neurochem. 63:2342-2345. (Pubitemid 24984049)
44. Wolf, K., H. J. Betts, B. Chellas-Gery, S. Hower, C. N. Linton, and K. A. Fields. 2006. Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle. Mol. Microbiol. 61:1543-1555.
45. +-ATPases on endocytosis and apoptosis in RAW cells and RAW cell-derived osteoclasts. J. Cell Biochem. 88:1256-1264.